Connective Portfolio Management, LLC Gilead Sciences, Inc. Transaction History

Connective Portfolio Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$76.01 - $86.7 $33,824 - $38,581	-445 Reduced 3.78%	11,325 $872,000
Q1 2023 Apr 17, 2023	SELL	$77.31 - $88.08 $1.55 Million - $1.76 Million	-20,000 Reduced 62.95%	11,770 $976,000
Q4 2022 Jan 25, 2023	BUY	$62.32 - $89.47 $1.25 Million - $1.79 Million	20,000 Added 169.92%	31,770 $0
Q3 2022 Oct 26, 2022	BUY	$59.54 - $68.01 $700,785 - $800,477	11,770 New	11,770 $726,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Connective Portfolio Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Connective Portfolio Management, LLC with notifications on news.